Roche Holding AG (OTCMKTS:RHHBY) Stock Holdings Raised by Boston Common Asset Management LLC

Boston Common Asset Management LLC raised its stake in Roche Holding AG (OTCMKTS:RHHBY - Free Report) by 10.0% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 325,732 shares of the company's stock after purchasing an additional 29,522 shares during the quarter. Boston Common Asset Management LLC's holdings in Roche were worth $13,369,000 at the end of the most recent quarter.

A number of other hedge funds also recently made changes to their positions in RHHBY. Verity Asset Management Inc. lifted its holdings in shares of Roche by 26.8% during the 4th quarter. Verity Asset Management Inc. now owns 8,036 shares of the company's stock valued at $280,000 after acquiring an additional 1,697 shares in the last quarter. HighPoint Advisor Group LLC lifted its holdings in shares of Roche by 2.8% during the 4th quarter. HighPoint Advisor Group LLC now owns 11,091 shares of the company's stock valued at $387,000 after acquiring an additional 304 shares in the last quarter. SVB Wealth LLC acquired a new position in shares of Roche during the 4th quarter valued at $555,000. Confluence Investment Management LLC lifted its holdings in shares of Roche by 3.6% during the 1st quarter. Confluence Investment Management LLC now owns 14,491 shares of the company's stock valued at $596,000 after acquiring an additional 510 shares in the last quarter. Finally, Minot DeBlois Advisors LLC acquired a new position in shares of Roche during the 4th quarter valued at $752,000.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on RHHBY. Morgan Stanley initiated coverage on shares of Roche in a report on Wednesday, February 12th. They set an "equal weight" rating on the stock. HSBC downgraded shares of Roche from a "buy" rating to a "hold" rating in a research note on Monday, April 28th. Hsbc Global Res downgraded shares of Roche from a "strong-buy" rating to a "hold" rating in a research note on Monday, April 28th. Sanford C. Bernstein raised shares of Roche to a "strong-buy" rating in a research note on Thursday, January 30th. Finally, UBS Group raised shares of Roche from a "hold" rating to a "strong-buy" rating in a research note on Thursday, February 13th. Two analysts have rated the stock with a sell rating, three have issued a hold rating, one has assigned a buy rating and two have issued a strong buy rating to the stock. According to MarketBeat, the stock has an average rating of "Hold".

Roche Trading Up 2.1%

Shares of RHHBY traded up $0.83 during midday trading on Friday, hitting $40.35. The company had a trading volume of 1,688,042 shares, compared to its average volume of 2,842,414. The company's 50 day moving average price is $39.26 and its 200 day moving average price is $38.67. Roche Holding AG has a 52 week low of $31.30 and a 52 week high of $44.31. The company has a debt-to-equity ratio of 0.86, a current ratio of 1.26 and a quick ratio of 0.97.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.